Growth Metrics

Jazz Pharmaceuticals (JAZZ) Cash from Operations (2016 - 2025)

Jazz Pharmaceuticals has reported Cash from Operations over the past 16 years, most recently at 362518000.0 for Q4 2025.

  • Quarterly Cash from Operations fell 9.05% to 362518000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1355773000.0 through Dec 2025, down 2.88% year-over-year, with the annual reading at 1355773000.0 for FY2025, 2.88% down from the prior year.
  • Cash from Operations was 362518000.0 for Q4 2025 at Jazz Pharmaceuticals, down from 474616000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 474616000.0 in Q3 2025 and troughed at 41695000.0 in Q2 2021.
  • The 5-year median for Cash from Operations is 305115500.0 (2022), against an average of 294708600.0.
  • Biggest five-year swings in Cash from Operations: crashed 77.16% in 2021 and later soared 626.79% in 2022.
  • Tracing JAZZ's Cash from Operations over 5 years: stood at 177755000.0 in 2021, then skyrocketed by 92.38% to 341971000.0 in 2022, then crashed by 51.07% to 167339000.0 in 2023, then soared by 138.19% to 398580000.0 in 2024, then decreased by 9.05% to 362518000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 362518000.0, 474616000.0, and 88855000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.